rs886039393
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000214.3(JAG1):c.2096_2100delGAAAG(p.Gly699AspfsTer6) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G699G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000214.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- Alagille syndrome due to a JAG1 point mutationInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- Charcot-Marie-Tooth disease, axonal, Type 2HHInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- tetralogy of fallotInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000214.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| JAG1 | NM_000214.3 | MANE Select | c.2096_2100delGAAAG | p.Gly699AspfsTer6 | frameshift | Exon 16 of 26 | NP_000205.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| JAG1 | ENST00000254958.10 | TSL:1 MANE Select | c.2096_2100delGAAAG | p.Gly699AspfsTer6 | frameshift | Exon 16 of 26 | ENSP00000254958.4 | ||
| JAG1 | ENST00000423891.6 | TSL:2 | n.1962_1966delGAAAG | non_coding_transcript_exon | Exon 14 of 25 | ||||
| JAG1 | ENST00000488480.2 | TSL:4 | n.493_497delGAAAG | non_coding_transcript_exon | Exon 2 of 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Alagille syndrome due to a JAG1 point mutation Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in JAG1 are known to be pathogenic. This particular variant has been reported in the literature in individuals affected with Alagille syndrome (PMID: 9585603). It is also called 2504del5 in the literature. This sequence change deletes 5 nucleotides from exon 16 of the JAG1 mRNA (c.2096_2100delGAAAG), causing a frameshift at codon 699. This creates a premature translational stop signal (p.Gly699Aspfs*6) and is expected to result in an absent or disrupted protein product.
not provided Pathogenic:2
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9585603)
Tetralogy of Fallot;C1866053:Deafness, congenital heart defects, and posterior embryotoxon;C1956125:Alagille syndrome due to a JAG1 point mutation;C5562003:Charcot-Marie-Tooth disease, axonal, Type 2HH Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at